The Concept of CMR

Epidemiology

Smoking

Smoking and Cardiovascular Health


Page: Go to Previous Page 4 of 9 Go to Next Page

It is well established that cigarette smoking is one of the most important modifiable risk factors for CHD (3, 5-14). The Centers for Disease Control and Prevention have reported that cigarette smokers are 2 to 4 times more likely to develop CHD than non-smokers (3). Smokers are also more than 10 times more likely to develop peripheral vascular disease than non-smokers. It has been estimated that cigarette smoking approximately doubles a person’s risk for stroke. The pooled relative risk of stroke associated with cigarette smoking was 1.5 in a meta-analysis conducted by Shinton et al. (9). In addition, the Atherosclerosis Risk in Communities (ARIC) Study showed that smoking-related CHD risk was much higher in the presence of higher LDL cholesterol (15). In the INTERHEART study, a myocardial infarction case-control study conducted in 52 countries, current smokers had a greater risk (odds ratio [OR]: 2.95) of acute myocardial infarction (AMI) compared to individuals who had never smoked. By shortening life, smoking decreases CVD probability and duration throughout the life course, though non-smokers live many years longer and are longer free of CVD than smokers (16). The risk associated with cigarette smoking varies with age, gender, ethnicity, amount of cigarettes smoked per day, and other factors. 


Reference
Previous Reference
Next Reference
3. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115: e69-171.
5. Wolf PA, D'Agostino RB, Belanger AJ, et al. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991; 22: 312-8.
6. Bonita R, Scragg R, Stewart A, et al. Cigarette smoking and risk of premature stroke in men and women. BMJ 1986; 293: 6-8.
7. Abbott RD, Yin Y, Reed DM, et al. Risk of stroke in male cigarette smokers. N Engl J Med 1986; 315: 717-20.
8. Colditz GA, Bonita R, Stampfer MJ, et al. Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med 1988; 318: 937-41.
9. Shinton R and Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989; 298: 789-94.
10. Haapanen A, Koskenvuo M, Kaprio J, et al. Carotid arteriosclerosis in identical twins discordant for cigarette smoking. Circulation 1989; 80: 10-6.
11. Whisnant JP, Homer D, Ingall TJ, et al. Duration of cigarette smoking is the strongest predictor of severe extracranial carotid artery atherosclerosis. Stroke 1990; 21: 707-14.
12. Howard G, Burke GL, Szklo M, et al. Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study. Arch Intern Med 1994; 154: 1277-82.
13. Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994; 309: 901-11.
14. Ockene IS and Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997; 96: 3243-7.
15. Hozawa A, Folsom AR, Sharrett AR, et al. Does the impact of smoking on coronary heart disease differ by low-density lipoprotein cholesterol level? the Atherosclerosis Risk in Communities (ARIC) Study. Circ J 2006; 70: 1105-10.
16. Mamun AA, Peeters A, Barendregt J, et al. Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study. Eur Heart J 2004; 25: 409-15.

Document Center


Role of the Dysregulated Endocannabinoid System in Determining Cardiometabolic Risk by Vincenzo Di Marzo, PhD

Role of the Dysregulated Endocannabinoid System in Determining Cardiometabolic Risk by Vincenzo Di Marzo, PhD

More

What is the role of low HDL cholesterol in the elevated CHD risk of metabolic syndrome patients? By Philip J. Barter, MBBS, FRACP, PhD

What is the role of low HDL cholesterol in the elevated CHD risk of metabolic syndrome patients? By Philip J. Barter, MBBS, FRACP, PhD

More

Waist circumference: Getting it right! By Robert Ross, PhD

Waist circumference: Getting it right! By Robert Ross, PhD

More

Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 2008;32:283-91

Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 2008;32:283-91

More

Schematic representation of how smoking might add to several mechanisms linking obesity to cardiovascular disease

Schematic representation of how smoking might add to several mechanisms linking obesity to cardiovascular disease

More